查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439426

核子醫學影像設備 - 全球市場考量、競爭格局、市場預測（2030）

Nuclear Imaging Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年全球核醫影像設備市場規模預估為25.7億美元，2030年將達31.3億美元，預計2024-2030年的複合年增長率為3.34%。 由於心血管疾病盛行率上升、癌症盛行率上升、老年人口增加以及產品技術進步等因素，該市場正在呈現積極成長。 因此，上述所有這些因素都將有助於2024-2030年預測期內的市場成長。

核醫影像設備市場動態

核醫影像設備市場的主要促進因素之一是心血管疾病的盛行率不斷上升。 根據世界衛生組織 (WHO) 2022 年發布的數據，最新統計數據顯示，心血管疾病 (CVD) 是全球最常見的死亡原因。 上述數據顯示，2019年有1,790萬人死於CVD，佔全球死亡人數的32%，其中85%是由於心臟病和中風所致。 因此，核醫影像設備用於診斷冠狀動脈疾病和心肌病變（心肌疾病）等疾病，以減少患有心血管疾病的人數以及由此導致的死亡。 因此，對核子醫學影像設備的需求將激增，從而增加預測期內（2024-2030年）核醫影像設備市場的整體成長。

此外，推動核醫影像設備市場成長的另一個主要因素可能是癌症盛行率的增加。 根據世界衛生組織（2022）的數據，癌症是全球頭號死因，2020年約有1,000萬人死亡，約佔死亡人數的六分之一。 乳癌、肺癌、結腸癌、直腸癌和攝護腺癌是最常見的惡性腫瘤。 根據上述數據，每年約有40萬名兒童罹患癌症。 因此，為了克服癌症發病率及其相關死亡率不斷上升的問題，醫生正在使用核醫學影像設備來識別患者體內擴散的腫瘤並尋找相關治療方法。這種方法將增加對核醫學影像設備的需求，從而導致在預測期內（2024-2030），整個核醫影像設備市場快速成長。

然而，也存在一些阻礙市場成長的障礙，例如核醫影像設備的高成本和核子管理委員會（NRC）的嚴格監管。

持續的 COVID-19 大流行影響了核醫影像設備市場，因為封鎖規定導致門診取消以及非緊急醫院和程序暫停。 擇期手術的優先順序較低，因為重點是確保 COVID-19 患者得到適當的治療。 但隨著更多人接種疫苗、封鎖規定放鬆、經濟復甦、經濟狀況恢復正常，門診等正常醫療服務也恢復，導致核醫影像設備市場將重新復甦預測期內的動能與成長。

核醫影像設備市場區隔分析

在核子醫學影像設備市場的產品類型領域，與單光子發射電腦斷層掃描 (SPECT) 設備相比，正子斷層掃描 (PET) 設備的需求量很大。 這可能是由於 PET 提供的多種優勢，因為它更容易合成新的示蹤劑，並且是比 SPECT 更靈活的工具。 此外，PET 的空間解析度明顯優於 SPECT，能夠定量估計血流。 這是由於正電子核衰變的物理特性。 與 SPECT 相比，PET 成像最重要的優勢是其顯著更高的靈敏度（高出 2-3 個數量級），這意味著可以檢測和記錄更大比例的發射事件，這具有重大意義。

本報告提供了全球核醫影像設備市場的研究和分析，包括市場規模和預測、促進因素和挑戰以及公司和產品概況。

目錄

第 1 章核醫影像設備市場報告簡介

第 2 章核醫影像設備市場摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估
  • 財務基準

第 3 章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第 4 章核醫影像設備市場主要因素分析

  • 核子醫學影像設備市場促進因素
    • 心血管疾病盛行率不斷上升
    • 癌症發生率上升
    • 老年人口增加
    • 產品方面的技術進步
  • 核醫影像設備市場的抑制因素與挑戰
    • 核子醫學影像設備成本高
    • 核管會 (NRC) 的嚴格規定
  • 核醫影像設備市場機遇
    • 增加子宮內避孕器的研發活動
    • 對人工智慧技術的需求不斷增加

第 5 章核醫影像設備市場波特五力分析

第 6 章COVID-19對核子醫學影像設備的影響分析

第 7 章核醫影像設備市場佈局

  • 依產品類型
    • 單光子發射電腦斷層掃描 (SPECT)
    • 正子斷層掃描 (PET)
  • 依用途
    • 腫瘤
    • 心
    • 緊張
    • 其他
  • 依最終使用者類型
    • 醫院
    • 影像診斷中心
    • 研究中心
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第 8 章核醫影像設備市場：全球公司份額分析 - 2至3家主要公司

第 9 章核醫影像設備市場公司及產品概況

  • Siemens Medical Solutions USA Inc
  • General Electric Company
  • Koninklijke Philips N.V
  • DIGIRAD CORPORATION
  • Neusoft Corporation
  • CANON MEDICAL SYSTEMS CORPORATION
  • SurgicEye GmbH
  • DDD-Diagnostic A/S
  • CMR Naviscan
  • Mediso Ltd
  • Shimadzu Corporation
  • MR Solutions
  • segamicorp
  • Spectrum Dynamics Medical
  • Cardinal Health
  • Curium SAS
  • BCL X-Ray Canada Inc
  • NeuroLogica Corp
  • Computerized Imaging Reference Systems Inc

第 10 章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡資訊

Product Code: DIMDCL0228

Nuclear Imaging Equipment Market By Product Type (Single-Photon Emission Computerized Tomography (Spect), Positron Emission Tomography (Pet)), By Application (Oncology, Cardiology, Neurology And Others), By End-User (Hospitals, Diagnostic Imaging Centers, And Research Centers), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of cardiovascular diseases and the increasing prevalence of cancers

The global Nuclear Imaging Market was valued at USD 2.57 billion in 2023, growing at a CAGR of 3.34% during the forecast period from 2024 to 2030, to reach USD 3.13 billion by 2030. The nuclear imaging equipment market is witnessing a positive growth owing to the factors such as, the rising prevalence of cardiovascular diseases, the increasing prevalence of cancers, increasing geriatric population and technological advancements in the product offerings. Thus, all these factors mentioned above are contributing to the growth of nuclear imaging equipment market during the forecast period from 2024-2030.

Nuclear Imaging Equipment Market Dynamics:

One of the main drivers of the nuclear imaging equipment market is the increasing prevalence of cardiovascular diseases. According to World Health Organization (WHO) data published in 2022, as per the latest statistics, cardiovascular diseases (CVDs) are the most common cause of mortality across the world. According to the above mentioned source, in 2019, 17.9 million people died from CVDs, accounting for 32% of all fatalities worldwide and 85% of these deaths were caused by heart attacks and strokes. Therefore, to reduce the number of people suffering with cardiovascular diseases and deaths associated with it, nuclear imaging equipment are used to diagnose coronary artery disease, cardiomyopathy in the heart (diseases of the heart muscle) and others. This will cause a surge in the demand for nuclear imaging equipment, which increases the nuclear imaging equipment overall market growth during the forecast period (2024-2030).

Moreover, another key factor that is responsible for the growth of the nuclear imaging equipment market can be the increasing prevalence of cancers. As per WHO 2022, cancer is the biggest cause of mortality globally, with approximately 10 million fatalities in 2020, accounting for roughly one in every six deaths. Breast, lung, colon, rectum, and prostate cancers are the most frequent malignancies. According to the above mentioned source, every year, approximately 400,000 children develop cancer. Thus, to overcome the increasing cancer rates & deaths linked with it, nuclear imaging equipment are used by doctors to identify the tumor spread in the patient's body and help to find the treatment associated with it, this approach tends to increase the demand for nuclear imaging equipment which leads to surge in the nuclear imaging equipment overall market during the forecast period (2024-2030).

However, the market will face certain barriers to growth as well, such as high cost of nuclear imaging equipment and strict regulations by the Nuclear Regulatory Commission (NRC) that can slow down the market growth.

The ongoing coronavirus pandemic has impacted the market for nuclear imaging equipment lockdown restrictions as it had led to cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. Elective surgeries were not on priority as COVID-19 patients were given more weightage pertaining to receiving adequate treatment. However, with masses being vaccinated, lockdown restriction relaxation has initiated the process of economic recovery and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits and resumption of healthcare services, allowing the nuclear imaging equipment market to pick momentum and grow in the forecast period.

Nuclear Imaging Equipment Market Segment Analysis:

Nuclear Imaging Equipment Market by Product Type (Single-Photon Emission Computerized Tomography (SPECT), Positron Emission Tomography (PET)), Application (Oncology, Cardiology, Neurology and Others), End-User (Hospitals, Diagnostic Imaging Centers, and Research Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In by-product type segment of nuclear imaging equipment market, the demand of Positron Emission Tomography (PET) is high as compared to the Single-Photon Emission Computerized Tomography (SPECT). This can be ascribed to several advantages that are offered by PET as it is a more flexible tool, because new tracers are easier to synthesize for PET than for SPECT. Furthermore, the spatial resolution, along with the capability to provide quantitative estimates of blood flow, PET is significantly superior to that of SPECT. This is owing to the physical nature of positron nuclear decay. The most significant benefit of PET imaging over SPECT is that it has a substantially better sensitivity (by two to three orders of magnitude) that is, it can detect and record a much larger percentage of the emitted events, which has major ramifications.

In November 2022, Telix Pharmaceuticals, a biopharmaceutical company, announced that the Australian Therapeutic Goods Administration (TGA) has approved Illuccix® (Kit for the preparation of 68Ga PSMA-11 Injection) is a positron emission tomography (PET) agent for the diagnostic imaging of men with prostate cancer.

Furthermore, the benefits associated with PET over SPECT, increases its demand which enhance the nuclear imaging equipment overall market during the forecast period from 2024-2030.

North America is expected to dominate the overall Nuclear Imaging Equipment Market:

Among all the regions, North America is expected to dominate the global nuclear imaging equipment market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. Factors such as the rising prevalence of cardiovascular diseases and technological advancements in the product offerings will drive the use of nuclear imaging equipment which increases the demand of nuclear imaging equipment in the North America market.

According to the Centers for Disease Control and Prevention (CDC) 2022, in the United States, as per the latest statistics, one person dies from cardiovascular disease in every 36 seconds. According to the above mentioned source, heart disease claim the lives of around 659,000 people in the United States each year, accounting for one out of every four fatalities. As per CDC, the most frequent kind of heart illness, coronary heart disease had killed 360,900 people in the year 2019. Furthermore, it had affected about 18.2 million people aged 20 and above (about 6.7%). Therefore, in order to treat the number of people suffering from cardiovascular diseases and to reduce the number of deaths related to it, nuclear imaging equipment are used to evaluate coronary artery disease, cardiomyopathy in the heart (diseases of the heart muscle) and others, this has further led to an increase in the demand of nuclear imaging equipment, which would surge the nuclear imaging equipment overall market during the forecast period (2024-2030).

Furthermore, another factor such as the technological advancements in the nuclear imaging equipment such as, in March 2022, at RSNA 2022, Philips, a health-tech company, highlighted the launch of two new cutting-edge CT systems: the multi-energy Spectral CT 7500 and the CT 5100 Incisive with integrated artificial intelligence.

Apart from this, in March 2022, NeuroLogica Corp, a Samsung Electronics Co. Ltd. subsidiary, announced that its state-of-the-art OmniTom Elite has received 510(k) clearance for the addition of Photon Counting Detector (PCD) technology. The company introduces the first single-source photon counting computed tomography (CT) scanner with single detector on a transportable device. OmniTom Elite with PCD is capable of producing spectral CT pictures at various energy levels. Therefore, such technological advancements in the nuclear imaging equipment, can increase the demand for nuclear imaging equipment, which could drive the nuclear imaging equipment overall market growth.

Therefore, due to interplay of the factors mentioned above, the demand for nuclear imaging equipment could boost, which in turn would provide a conducive growth environment in North American region for the nuclear imaging equipment during market forecast 2024-2030.

Nuclear Imaging Equipment Market Key Players:

Some of the key market players operating in the nuclear imaging equipment market include Siemens Medical Solutions USA Inc, General Electric Company, Koninklijke Philips N.V., DIGIRAD CORPORATION, Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, SurgicEye GmbH, DDD-Diagnostic A/S, CMR Naviscan, Mediso Ltd, Shimadzu Corporation, MR Solutions, segamicorp, Spectrum Dynamics Medical, Cardinal Health, Curium SAS, BCL X-Ray Canada Inc, NeuroLogica Corp, Computerized Imaging Reference Systems, Inc, and among others.

Recent Developmental Activities in the Nuclear Imaging Equipment:

  • In May 2022, Mediso Ltd, a Hungarian manufacturer of nuclear medicine imaging equipment, announced the acquisition of Bartec Technologies Ltd, UK based company specialized in the supply, installation and support of Nuclear Medicine and Molecular Imaging equipment and accessories.
  • In December 2022, Computerized Imaging Reference Systems, Inc., a leading provider of medical imaging and radiation therapy phantoms serving the medical industry, has been acquired by Mirion Technologies, Inc., a global provider of detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets.
  • In April 2020, TTG Imaging Solutions, LLC, announced that it has acquired Nuclear Imaging Services and its Texas-based radiopharmacy. The company also announced it had acquired Molecular Imaging Specialists, a medical imaging equipment and service provider in Ft. Lauderdale.

Key Takeaways from the Nuclear Imaging Equipment Market Report Study

  • Market size analysis for current nuclear imaging equipment market size (2023), and market forecast for 5 years (2024-2030).
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Nuclear imaging equipment.
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint venture happened for last 3 years.
  • Key companies dominating the global nuclear imaging equipment.
  • Various opportunities are available for the other competitor in the Nuclear imaging equipment Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current nuclear imaging equipment Market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Nuclear imaging equipment Market growth in the coming future?

Target Audience who can be benefited from this Nuclear Imaging Equipment Market Report Study

  • Nuclear imaging equipment products providers
  • Research organizations and consulting companies
  • Nuclear imaging equipment-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in nuclear imaging equipment
  • Various End-users who want to know more about the nuclear imaging equipment Market and latest technological developments in the nuclear imaging equipment.

Frequently Asked Questions for Nuclear Imaging Equipment:

1. What are Nuclear Imaging Equipment?

A unique gamma camera and single-photon emission computed tomography (SPECT) imaging methods are used in nuclear medicine. The gamma camera captures and transforms the energy emitted by the radiotracer in the body into a picture.

2. What is the market for Global Nuclear Imaging Equipment?

The global nuclear imaging equipment Market was valued at USD 2.57 billion in 2023, growing at a CAGR of 3.34% during the forecast period from 2024 to 2030 to reach USD 3.13 billion by 2030.

3. What are the drivers for the Global Nuclear Imaging Equipment Market?

The nuclear imaging equipment market is witnessing a positive market growth owing to the factors such as, the rising prevalence of cardiovascular diseases, the increasing prevalence of cancers, increasing geriatric population and technological advancements in the product offerings

4. Who are the key players operating in the Nuclear Imaging Equipment Market?

Some of the key market players operating in the nuclear imaging equipment market include Siemens Medical Solutions USA Inc, General Electric Company, Koninklijke Philips N.V., DIGIRAD CORPORATION, Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, SurgicEye GmbH, DDD-Diagnostic A/S, CMR Naviscan, Mediso Ltd, Shimadzu Corporation, MR Solutions, segamicorp, Spectrum Dynamics Medical, Cardinal Health, Curium SAS, BCL X-Ray Canada Inc, NeuroLogica Corp, Computerized Imaging Reference Systems, Inc, and among others.

5. Which region has the highest share in Nuclear Imaging Equipment Market?

North America is expected to dominate the global nuclear imaging equipment market. Factors contributing to the growth are the rising prevalence of cardiovascular diseases and technological advancements in the product offerings drives the nuclear imaging equipment market growth in this region.

Table of Contents

1.Nuclear Imaging Equipment Market Report Introduction

2.Nuclear Imaging Equipment Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The US
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Nuclear Imaging Equipment Market Key Factors Analysis

  • 4.1. Nuclear Imaging Equipment Market Drivers
    • 4.1.1. The Rising Prevalence of Cardiovascular Diseases
    • 4.1.2. The Increasing Prevalence of Cancers
    • 4.1.3. Increasing Geriatric Population
    • 4.1.4. Technological Advancements in the Product Offerings
  • 4.2. Nuclear Imaging Equipment Market Restraints And Challenges
    • 4.2.1. High Cost of Nuclear Imaging Equipment
    • 4.2.2. Strict Regulations by the Nuclear Regulatory Commission (NRC)
  • 4.3. Nuclear Imaging Equipment Market Opportunities
    • 4.3.1. Increasing Research and Development Activities in Intrauterine Devices
    • 4.3.2. Growing Demand for the Artificial Intelligence Technology

5. Nuclear Imaging Equipment Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Nuclear Imaging Equipment

7. Nuclear Imaging Equipment Market Layout

  • 7.1. By Product Type
    • 7.1.1. Single-Photon Emission Computerized Tomography (SPECT)
    • 7.1.2. Positron Emission Tomography (PET)
  • 7.2. By Application
    • 7.2.1. Oncology
    • 7.2.2. Cardiology
    • 7.2.3. Neurology
    • 7.2.4. Others
  • 7.3. By End User Type
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Imaging Centers
    • 7.3.3. Research Centers
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Nuclear Imaging Equipment Market, by Country
      • 7.4.1.1.1. US
      • 7.4.1.1.2. Canada
      • 7.4.1.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Nuclear Imaging Equipment Market, by Country
      • 7.4.2.1.1. France
      • 7.4.2.1.2. Germany
      • 7.4.2.1.3. United Kingdom
      • 7.4.2.1.4. Italy
      • 7.4.2.1.5. Spain
      • 7.4.2.1.6. Russia
      • 7.4.2.1.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Nuclear Imaging Equipment Market, by Country
      • 7.4.3.1.1. China
      • 7.4.3.1.2. Japan
      • 7.4.3.1.3. India
      • 7.4.3.1.4. Australia
      • 7.4.3.1.5. South Korea
      • 7.4.3.1.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.3.4.1. RoW Intrauterine Devices Market, by Region
      • 7.3.4.1.1. Middle East
      • 7.3.4.1.2. Africa
      • 7.3.4.1.3. South America

8. Nuclear Imaging Equipment Market Global Company Share Analysis - Key 2-3 Companies

9. Nuclear Imaging Equipment Market Company and Product Profiles

  • 9.1. Siemens Medical Solutions USA Inc
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. General Electric Company
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Koninklijke Philips N.V
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. DIGIRAD CORPORATION
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Neusoft Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. CANON MEDICAL SYSTEMS CORPORATION
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. SurgicEye GmbH
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. DDD-Diagnostic A/S
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. CMR Naviscan
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Mediso Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Shimadzu Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. MR Solutions
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. segamicorp
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Spectrum Dynamics Medical
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Cardinal Health
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Curium SAS
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. BCL X-Ray Canada Inc
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. NeuroLogica Corp
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Computerized Imaging Reference Systems Inc
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Nuclear Imaging Equipment Market in Global (2021-2030)
  • Table 4: Nuclear Imaging Equipment Market in Global by Product Type (2021-2030)
  • Table 5: Nuclear Imaging Equipment Market in Global by Application (2021-2030)
  • Table 6: Nuclear Imaging Equipment Market in Global by End User Type (2021-2030)
  • Table 7: Nuclear Imaging Equipment Market in Global by Geography (2021-2030)
  • Table 8: Nuclear Imaging Equipment Market in North America (2021-2030)
  • Table 9: Nuclear Imaging Equipment Market in North America by Country (2021-2030)
  • Table 10: Nuclear Imaging Equipment Market in the US (2021-2030)
  • Table 11: Nuclear Imaging Equipment Market in Canada (2021-2030)
  • Table 12: Nuclear Imaging Equipment Market in Mexico (2021-2030)
  • Table 13: Nuclear Imaging Equipment Market in Europe (2021-2030)
  • Table 14: Nuclear Imaging Equipment Market in Europe by Country (2021-2030)
  • Table 15: Nuclear Imaging Equipment Market in France (2021-2030)
  • Table 16: Nuclear Imaging Equipment Market in Germany (2021-2030)
  • Table 17: Nuclear Imaging Equipment Market in the United Kingdom (2021-2030)
  • Table 18: Nuclear Imaging Equipment Market in Italy (2021-2030)
  • Table 19: Nuclear Imaging Equipment Market in Spain (2021-2030)
  • Table 20: Nuclear Imaging Equipment Market in Russia (2021-2030)
  • Table 21: Nuclear Imaging Equipment Market in Rest of Europe (2021-2030)
  • Table 22: Nuclear Imaging Equipment Market in APAC (2021-2030)
  • Table 23: Nuclear Imaging Equipment Market in APAC by Country (2021-2030)
  • Table 24: Nuclear Imaging Equipment Market in China (2021-2030)
  • Table 25: Nuclear Imaging Equipment Market in Japan (2021-2030)
  • Table 26: Nuclear Imaging Equipment Market in India (2021-2030)
  • Table 27: Nuclear Imaging Equipment Market in Australia (2021-2030)
  • Table 28: Nuclear Imaging Equipment Market in South Korea (2021-2030)
  • Table 29: Nuclear Imaging Equipment Market in Rest of APAC (2021-2030)
  • Table 30: Nuclear Imaging Equipment Market in Rest of World (2021-2030)
  • Table 31: Nuclear Imaging Equipment Market in Middle East (2021-2030)
  • Table 32: Nuclear Imaging Equipment Market in Africa (2021-2030)
  • Table 33: Nuclear Imaging Equipment Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Nuclear Imaging Equipment Market in Global (2021-2030)
  • Figure 4: Nuclear Imaging Equipment Market in Global by Product Type (2021-2030)
  • Figure 5: Nuclear Imaging Equipment Market in Global by Application (2021-2030)
  • Figure 6: Nuclear Imaging Equipment Market in Global by End User Type (2021-2030)
  • Figure 7: Nuclear Imaging Equipment Market in Global by Geography (2021-2030)
  • Figure 8: Nuclear Imaging Equipment Market in North America (2021-2030)
  • Figure 9: Nuclear Imaging Equipment Market in North America by Country (2021-2030)
  • Figure 10: Nuclear Imaging Equipment Market in the US (2021-2030)
  • Figure 11: Nuclear Imaging Equipment Market in Canada (2021-2030)
  • Figure 12: Nuclear Imaging Equipment Market in Mexico (2021-2030)
  • Figure 13: Nuclear Imaging Equipment Market in Europe (2021-2030)
  • Figure 14: Nuclear Imaging Equipment Market in Europe by Country (2021-2030)
  • Figure 15: Nuclear Imaging Equipment Market in France (2021-2030)
  • Figure 16: Nuclear Imaging Equipment Market in Germany (2021-2030)
  • Figure 17: Nuclear Imaging Equipment Market in the United Kingdom (2021-2030)
  • Figure 18: Nuclear Imaging Equipment Market in Italy (2021-2030)
  • Figure 19: Nuclear Imaging Equipment Market in Spain (2021-2030)
  • Figure 20: Nuclear Imaging Equipment Market in Russia (2021-2030)
  • Figure 21: Nuclear Imaging Equipment Market in Rest of Europe (2021-2030)
  • Figure 22: Nuclear Imaging Equipment Market in APAC (2021-2030)
  • Figure 23: Nuclear Imaging Equipment Market in APAC by Country (2021-2030)
  • Figure 24: Nuclear Imaging Equipment Market in China (2021-2030)
  • Figure 25: Nuclear Imaging Equipment Market in Japan (2021-2030)
  • Figure 26: Nuclear Imaging Equipment Market in India (2021-2030)
  • Figure 27: Nuclear Imaging Equipment Market in Australia (2021-2030)
  • Figure 28: Nuclear Imaging Equipment Market in South Korea (2021-2030)
  • Figure 29: Nuclear Imaging Equipment Market in Rest of APAC (2021-2030)
  • Figure 30: Nuclear Imaging Equipment Market in Rest of World (2021-2030)
  • Figure 31: Market Drivers
  • Figure 32: Market Barriers
  • Figure 33: Marker Opportunities
  • Figure 34: PORTER'S Five Force Analysis